The estimated Net Worth of Christopher J Scoggins is at least $10 Milhão dollars as of 1 February 2021. Mr. Scoggins owns over 45,000 units of Abbott Laboratories stock worth over $9,876,720 and over the last 6 years he sold ABT stock worth over $136,369. In addition, he makes $0 as Senior Vice President - Rapid Diagnostics at Abbott Laboratories.
Christopher has made over 3 trades of the Abbott Laboratories stock since 2020, according to the Form 4 filled with the SEC. Most recently he exercised 45,000 units of ABT stock worth $2,017,350 on 1 February 2021.
The largest trade he's ever made was exercising 45,000 units of Abbott Laboratories stock on 1 February 2021 worth over $2,017,350. On average, Christopher trades about 5,184 units every 38 days since 2019. As of 1 February 2021 he still owns at least 84,706 units of Abbott Laboratories stock.
You can see the complete history of Mr. Scoggins stock trades at the bottom of the page.
Christopher J. Scoggins serves as Senior Vice President - Rapid Diagnostics of the Company. He serve as Vice President, Diabetes Care, Commercial Operations from 2015-2019. Divisional Vice President, EMEA Commercial Operations, ADC. from 2011-2015.
Christopher Scoggins is 50, he's been the Senior Vice President - Rapid Diagnostics of Abbott Laboratories since 2019. There are 35 older and 7 younger executives at Abbott Laboratories. The oldest executive at Abbott Laboratories is Samuel Scott, 75, who is the Independent Director.
Christopher's mailing address filed with the SEC is 100 ABBOTT PARK ROAD, , ABBOTT PARK, IL, 60064.
Over the last 24 years, insiders at Abbott Laboratories have traded over $388,257,551 worth of Abbott Laboratories stock and bought 1,028,477 units worth $44,923,618 . The most active insiders traders include Miles D White, Richard A Gonzalez, eJeffrey M Leiden. On average, Abbott Laboratories executives and independent directors trade stock every 9 days with the average trade being worth of $4,003,344. The most recent stock trade was executed by John A. Jr. Mccoy on 1 September 2024, trading 27 units of ABT stock currently worth $3,100.
Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States.
Abbott Laboratories executives and other stock owners filed with the SEC include: